These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 17514497)
1. Absorption, tissue distribution, metabolism and elimination of taurine given orally to rats. Sved DW; Godsey JL; Ledyard SL; Mahoney AP; Stetson PL; Ho S; Myers NR; Resnis P; Renwick AG Amino Acids; 2007; 32(4):459-66. PubMed ID: 17514497 [TBL] [Abstract][Full Text] [Related]
2. Relative contribution of diet and biosynthesis to the taurine content of the adult rat. Huxtable RJ; Lippincott SE Drug Nutr Interact; 1982; 1(2):153-68. PubMed ID: 6926824 [TBL] [Abstract][Full Text] [Related]
3. Optimal and effective oral dose of taurine to prolong exercise performance in rat. Miyazaki T; Matsuzaki Y; Ikegami T; Miyakawa S; Doy M; Tanaka N; Bouscarel B Amino Acids; 2004 Dec; 27(3-4):291-8. PubMed ID: 15503230 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design. Saghir SA; Clark AJ; McClymont EL; Staley JL Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896 [TBL] [Abstract][Full Text] [Related]
5. Distribution of radio-labeled N-Acetyl-L-Cysteine in Sprague-Dawley rats and its effect on glutathione metabolism following single and repeat dosing by oral gavage. Arfsten DP; Johnson EW; Wilfong ER; Jung AE; Bobb AJ Cutan Ocul Toxicol; 2007; 26(2):113-34. PubMed ID: 17612979 [TBL] [Abstract][Full Text] [Related]
6. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats. Fukano Y; Kawazu K Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946 [TBL] [Abstract][Full Text] [Related]
7. Metabolism of [35S]taurine in man. Sturman JA; Hepner GW; Hofmann AF; Thomas PJ J Nutr; 1975 Sep; 105(9):1206-14. PubMed ID: 1159536 [TBL] [Abstract][Full Text] [Related]
8. Increased excretion of taurine, hypotaurine and sulfate after hypotaurine loading and capacity of hypotaurine metabolism in rats. Fujiwara M; Ubuka T; Abe T; Yukihiro K; Tomozawa M Physiol Chem Phys Med NMR; 1995; 27(2):131-7. PubMed ID: 7568416 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration. Gradolatto A; Basly JP; Berges R; Teyssier C; Chagnon MC; Siess MH; Canivenc-Lavier MC Drug Metab Dispos; 2005 Jan; 33(1):49-54. PubMed ID: 15466493 [TBL] [Abstract][Full Text] [Related]
10. The effect of taurine administration on vitamin C levels of several tissues in mice. Kaplan B; Dinçer S; Babül A; Duyar I Amino Acids; 2004 Oct; 27(2):225-8. PubMed ID: 15503229 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioavailability of diisopropanolamine (DIPA) in rats following intravenous or dermal application. Saghir SA; Frantz SW; Spence MW; Nolan RJ; Lowe ER; Rick DL; Bartels MJ Food Chem Toxicol; 2007 Oct; 45(10):2047-56. PubMed ID: 17583405 [TBL] [Abstract][Full Text] [Related]
12. Tissue residues, metabolism, and excretion of radiolabeled sodium chlorate (Na[36Cl]O3) in rats. Hakk H; Smith DJ; Shappell NW J Agric Food Chem; 2007 Mar; 55(5):2034-42. PubMed ID: 17279768 [TBL] [Abstract][Full Text] [Related]
13. The absorption, distribution, metabolism and elimination of bevirimat in rats. Bullock P; Larsen D; Press R; Wehrman T; Martin DE Biopharm Drug Dispos; 2008 Oct; 29(7):396-405. PubMed ID: 18615840 [TBL] [Abstract][Full Text] [Related]
14. Tissue distribution and elimination of N-methyl-N-2,4,6-tetranitroaniline (tetryl) in rats. Myers SR; Spinnato JA Arch Toxicol; 2007 Dec; 81(12):841-8. PubMed ID: 17680234 [TBL] [Abstract][Full Text] [Related]
15. [14C]bis(2-chloroethoxy)methane: comparative absorption, distribution, metabolism and excretion in rats and mice. Black SR; Decosta KS; Patel PR; Mathews JM Xenobiotica; 2007 Apr; 37(4):427-40. PubMed ID: 17455114 [TBL] [Abstract][Full Text] [Related]
16. Metabolism distribution and excretion of a matrix metalloproteinase-13 inhibitor, 4-[4-(4-fluorophenoxy)-benzenesulfonylamino]tetrahydropyran-4-carboxylic acid hydroxyamide (CP-544439), in rats and dogs: assessment of the metabolic profile of CP-544439 in plasma and urine of humans. Dalvie D; Cosker T; Boyden T; Zhou S; Schroeder C; Potchoiba MJ Drug Metab Dispos; 2008 Sep; 36(9):1869-83. PubMed ID: 18566038 [TBL] [Abstract][Full Text] [Related]
17. Tissue distribution and elimination of selected chlorinated naphthalenes. Kilanowicz A; Galoch A; Sapota A Int J Occup Med Environ Health; 2004; 17(3):355-60. PubMed ID: 15683156 [TBL] [Abstract][Full Text] [Related]
18. A pharmacokinetic model for predicting absorption, elimination, and tissue burden of toxaphene in rats. Wen YH; Chan HM Toxicol Appl Pharmacol; 2000 Nov; 168(3):235-43. PubMed ID: 11042096 [TBL] [Abstract][Full Text] [Related]
19. 3,4-Dichlorobenzyloxyacetic acid is extensively metabolized to a taurine conjugate in rats. Peffer RC; Abraham DJ; Zemaitis MA; Wong LK; Alvin JD Drug Metab Dispos; 1987; 15(3):305-11. PubMed ID: 2886304 [TBL] [Abstract][Full Text] [Related]
20. Taurine supplementation improves the utilization of sulfur-containing amino acids in rats continually administrated alcohol. Yang HT; Chien YW; Tsen JH; Chang CC; Chang JH; Huang SY J Nutr Biochem; 2009 Feb; 20(2):132-9. PubMed ID: 18547794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]